Ipamorelin research: what changed in animals and what happened in people.
For every study, you'll learn who took part, what moved, and how far the result can reach.
What the Ipamorelin studies can tell you
Five protein parts joined in a lab make the peptide called ipamorelin. In 1998, tests showed that the drug made the growth gland send out growth hormone. The main stress hormone stayed level, so scientists called ipamorelin selective.
Later animal work included 1 bone study, along with tests of body fat and weight loss. Researchers also checked a growth signal made by the liver. Those findings may help your doctor ask sharper questions, but they cannot promise how your body will respond.
Human work is far thinner. One study measured how quickly ipamorelin left the blood. Phase 2, the first stage that looks for help with an illness, placed the drug in patients recovering from bowel surgery. The trial came up short, and the papers don't show whether you'll feel better or how your blood tests might change.
What Ipamorelin raises and what it leaves alone
Ghrelin is your body's hunger hormone, and ipamorelin imitates its call. Cells in the small growth gland under the brain answer with a short growth-hormone burst [1]. That link helps explain why your hunger may rise too.
Scientists first tested rat gland cells, then live rats and pigs. In pigs, 2.3 nanomoles per kilogram worked about as well as GHRP-6, an older growth-hormone test drug; a nanomole is a lab measure for a tiny amount. More than 200 times that amount still left the stress and milk-making hormones near their starting levels [1].
Older test drugs called GHRP-6 and GHRP-2 may raise all three hormones. Drug makers changed 1 protein part so ipamorelin would resist being broken apart. The narrow hormone result led scientists to call ipamorelin selective [1].
What Ipamorelin peptide is made from
A laboratory makes ipamorelin peptide by joining five protein parts into a short chain that your body never makes on its own. The chain imitates ghrelin, a hunger hormone, so the small growth gland sends out growth hormone [1].
Animal tests did not show a matching rise in either the main stress hormone or the milk-making hormone [1]. Scientists use the word selective for that narrow action. Although sellers offer ipamorelin for research, no drug agency has accepted it as medicine.
What Ipamorelin changed in bone, bowel, and weight tests
Adult female rats received ipamorelin beneath the skin for 15 days. Their daily amounts were 18, 90, and 450 micrograms. Without the drug, bone length grew 42 micrometers per day. With ipamorelin, the rates were 44, 50, and 52 micrometers per day [4].
The study reported 1 clear bone result: higher amounts went with faster growth. It also reported 1 different blood result: a growth signal made by the liver did not rise. Researchers found the change in bone near the growing area. A rat test can't tell you what would happen to your bones.
Ipamorelin also moves the bowel, so researchers later tried it after surgery. Two weeks of twice-daily use in mice raised fat-pad weight and leptin, which fat cells release. The rise happened whether the normal growth-hormone system worked or not [14].
In a 2024 test, sick ferrets received 1–3 milligrams per kilogram inside the belly. A cancer drug had made them ill. The ferrets lost about 24% less weight later in the study [5]. They still vomited, and holding weight during illness isn't a human fat-loss result.
What Ipamorelin did in the human studies
The first human study asked how healthy men's bodies handled ipamorelin. Five amounts were tried in groups of 8 men through a 15-minute drip. The range was 4.21–140.45 nanomoles for each kilogram a man weighed; a nanomole is a lab measure for a tiny amount, not a home-dose guide.
Half the drug left the blood in about 2 hours, and growth hormone reached its top reading near 40 minutes [2]. The study measured blood changes, not whether anyone felt better or what those changes meant for you and your doctor.
Only one Phase 2 trial came later; that stage checks for a first sign of benefit in patients. The trial enrolled 114 adults having bowel surgery. For up to 7 days, they received 0.03 milligrams per kilogram through a vein twice daily. They ate sooner on paper, but chance could explain the gap [3].
The paper counted any new health problem after treatment, not just harm blamed on the drug. Such problems were common in both groups [3], and that broad count can include troubles after surgery. Researchers found neither a clear new drug harm nor proof of benefit in this short trial.
No larger patient test, called Phase 3, came next. Three 2026 reviews agreed that the animal results deserve study [16][17][18], but they found no repeatable human benefit. Use outside a trial may still put your health at risk.
Whether cjc-1295 with Ipamorelin works in people
A fair human trial has never tested cjc-1295 ipamorelin as one pair [3]. Claims about sleep, strength, fat, or healing come from separate studies where no one received both drugs.
After one shot in healthy adults, CJC-1295 kept growth hormone higher by 2- to 10-fold for 6+ days [10]. Researchers measured 1 growth signal made by the liver, and it rose as well. Ipamorelin alone caused a shorter burst [2].
Those actions explain the interest, but they don't show a health gain for you. The pair could bring risks that separate studies missed, which makes the missing test of both drugs the key fact.
What is cjc 1295 Ipamorelin
The words cjc 1295 ipamorelin name two drugs used together, not one medicine. CJC-1295 keeps the body's usual request for growth hormone working longer [10]. Ipamorelin follows the hunger hormone's route and causes a shorter rise [1]. Both drugs act on the same growth gland, but in different ways.
That difference explains why people pair the drugs. Researchers still haven't tested them together in a fair human trial. Results for either drug alone can't show what both will do or tell you whether the pair is safe [10].
What Ipamorelin cjc-1295 may do together
Ipamorelin brings a short hormone burst, while CJC-1295 keeps the body's usual request to the growth gland working longer. Studies of other two-drug pairs released more growth hormone than either drug alone [10][11]. That is why scientists want to test the CJC-1295 and ipamorelin pair.
In 1 older 30-day study, a drug pair kept growth hormone and a liver-made growth signal above their starting levels [10]. Another study found that a different pair produced more hormone together [11]. Neither test used ipamorelin, so neither result shows that this pairing will help you.
What changes with Ipamorelin vs sermorelin
Ipamorelin and sermorelin send different messages that both end with more growth hormone. The first drug imitates ghrelin, your natural hunger hormone, and causes a short burst [1]. Sermorelin instead repeats the body's normal request to the growth gland [8].
One review discussed sermorelin for adults with low growth hormone [8], but did not compare it directly with ipamorelin. People may use both types because the messages begin differently. That custom does not prove that either drug, alone or paired, will help you.
What changes with Ipamorelin vs tesamorelin
Ipamorelin and tesamorelin also start the growth gland in different ways [1]. Tesamorelin copies the body's usual call for growth hormone. Ipamorelin copies ghrelin, the hunger hormone. The biggest difference, though, is their standing as medicines.
Ipamorelin has no approved use [3][7]. Tesamorelin does have an approved use for a set group of patients. That approval doesn't make the two drugs equal or safe to swap. No head-to-head trial tells you which would work better.